-
Genomic Vision Launches HexaCard, a New Service to CharacterizeCell Lines Used for Biomanufacturing and Cell & Gene Therapy
PharmaSources
July 18, 2023
Genomic Vision Launches HexaCard, a New Service to CharacterizeCell Lines Used for Biomanufacturing and Cell & Gene Therapy.
-
Genomic Vision Enters Distribution Agreement with CliniSciences
PharmaSources
June 26, 2023
On June 22, 2023,Genomic Vision, a Euronext-listed biotechnology company that develops products and services for the highly accurate characterization of DNA sequences, is pleased to announce an exclusive European distribution agreement with CliniSciences.
-
Simplifying AI Data Analysis for Scientists – as REPROCELL, IBM and STFC Hartree Centre Successfully Launch Pharmacology-AI Platform
PharmaSources
June 05, 2023
On June 1,2023,REPROCELL announces the launch of a new commercial service, Pharmacology-AI.
-
UK genomics market valued at over £5bn, according to new report
pharmatimes
August 02, 2021
A new report has revealed the strength of the UK’s genomics sector for investors, patients and the UK economy, adding that the sector has a market of over £5bn.
-
Lifebit Awarded A Four-Year Contract for Hong Kong, S.A.R., China's Genome Project
prnasia
May 25, 2021
The leader in precision medicine technology, Lifebit Biotech Ltd, today announced it has been awarded a four-year contract by Hong Kong, S.A.R., China Genome Institute (HKGI) to support its implementation of the first large-scale genome sequencing initiat
-
Genomics plc scores $30m to expand patient-centric health platform
pharmatimes
March 02, 2021
Oxford, UK-based Genomics plc has completed a $30m funding round, which the company will use to expand its work on its patient-centric, population health platform.
-
BC Platforms partners with IQVIA to Extend Data Analytics in Genomics
biospectrumasia
December 18, 2019
BC Platforms, a world leader in genomic data management and analytics, today announced that it has closed a USD $15 million financing round alongside a new commercial collaboration with IQVIA™.
-
BC Platforms to expand Genotyping services across Europe
biospectrumasia
December 09, 2019
BC Platforms, a world leader in genomic data management and analytics, on 6 Dec 2019 announced that it has formed a partnership with Life &Brain Genomics, a division of Life & Brain GmbH.
-
Genomics England completes first phase of liquid biopsy study
pharmatimes
April 16, 2019
Genomics England has announced the successful completion of the first phase of its study assessing plasma samples and potential of liquid biopsy.
-
UCB and Epilepsy Society partner to bring targeted treatments
pharmaceutical-technology
February 13, 2019
Belgian biopharmaceutical firm UCB has partnered with non-profit Epilepsy Society in the UK to provide targeted treatments for epilepsy patients whose seizures do not respond to existing therapies....